Answers are grounded in this paper and cite their sources.
BACKGROUND: Chronic kidney disease (CKD) is increasing rapidly in African populations, yet its molecular determinants remain poorly characterised. While epigenome-wide studies have been largely confined to high-income settings, comparable longitudinal epigenetic data from African populations are scarce, despite distinct genetic and environmental contexts. We conducted a longitudinal epigenome-wide study of CKD in an African population, integrating DNA methylation and gene expression to identify epigenetic changes associated with CKD and related kidney function decline. METHODS: DNA methylation was profiled using the Illumina EPIC (850K) array in 274 Ghanaian participants from the RODAM-Prospective cohort (92 incident CKD cases and 182 matched controls), providing 548 DNA methylation observations across baseline and ∼6-year follow-up, with high-quality DNA methylation data available at both timepoints. Epigenome-wide association studies (EWAS) were performed for incident CKD, change in estimated glomerular filtration rate (ΔeGFR), and change in urinary albumin-to-creatinine ratio (ΔACR), adjusting for demographic, clinical, and technical covariates. Differentially methylated regions (DMRs) were identified using bumphunter with family-wise error rate control. Differential gene expression (RNA-seq) analyses were conducted, followed by covariate-adjusted expression quantitative trait methylation (eQTM) analyses to link methylation with gene expression. FINDINGS: At baseline, significant differentially methylated positions (DMPs) were detected at INF2 (incident CKD), CLIP4 (ΔeGFR), and TMEM109 (ΔACR), alongside DMRs at HLA-DPB1 and SH2D1B (incident CKD) and ZFP57 and OR2T11 (ΔACR). At follow-up, a progression-related DMR in C4orf39/TRIM61 (ΔACR) was identified, with recurrent signals at hypermethylated HLA-DPB1 and hypomethylated ZFP57 and OR2T11 across timepoints. Integrative eQTM analysis revealed methylation-expression associations at recurrent loci including ZFP57, HLA-DRB5, SLC39A4, and SPATC1L, with predominantly inverse associations at ZFP57, HLA-DRB5, and SLC39A4, highlighting associations with metabolic and immune regulatory pathways. INTERPRETATION: We identified epigenetic changes associated with incident CKD and kidney function decline in an African population. These methylation signals, supported by gene expression patterns, highlight immune and kidney-related pathways associated with CKD risk and progression. Our findings provide a foundation for future studies investigating the potential of epigenetic markers in CKD risk stratification and prevention in African populations.
No takes yet. Share an insight, caveat, or question.
Mungamba et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: